Sleep Sensing is a new innovation in the latest version of Google Nest Hub …
Sleep Sensing is a new innovation in the latest version of Google Nest Hub …
… Google introduces Sleep Sensing in the new Google Nest Hub …

New Nest Hub “Sleep Sensing” application provides an array of rest quality monitoring measurements

John G. Baresky

Google, a business unit of Alphabet (NASDAQ: GOOGL) has introduced a new generation of Nest Hub technology that will help its users monitor the quality of their restfulness. The new Nest Hub combines several ambient sensory technologies to provide composite insights to user sleep patterns with its opt-in Sleep Sensing program.

Google is addressing an important underlying healthcare issue as the Centers for Disease Control and Prevention estimates about 70 million people in the United States do not get enough sleep.

The new Nest Hub Sleep Sensing application monitors and compiles data from several human rest and…


Pfizer COVID-19 clinical trials: antiviral PF-07321332 and Pfizer antiviral PF-07304814
Pfizer COVID-19 clinical trials: antiviral PF-07321332 and Pfizer antiviral PF-07304814
… Pfizer researching oral and IV COVID-19 antiviral therapies PF-07321332 and PF-07304814

John G. Baresky

Global pharmaceutical giant Pfizer (NYSE: PFE) is evaluating antiviral product pipeline candidates to treat COVID-19 via oral administration as well as IV therapy.

The promising new oral drug candidate, designated as PF-07321332, is being evaluated in a Phase 1, randomized, double-blind, sponsor-open, placebo-controlled, single- and multiple-dose escalation study to evaluate its safety, tolerability, and pharmacokinetics in healthy adult patients.

The experimental compound is classified as a protease inhibitor. Protease inhibitors prevent viruses from multiplying by selectively binding to viral proteases and blocking the proteolytic cleavage of protein precursors that are required for viruses to replicate.

Protease inhibitors…


Grand Rounds and Doctor On Demand Merge Their Enterprises
Grand Rounds and Doctor On Demand Merge Their Enterprises
… Grand Rounds and Doctor On Demand Team Up …

Telehealth growth opportunities surge ahead as competition mounts

John G. Baresky

Grand Rounds and Doctor On Demand have announced plans to merge and form a larger, more competitive enterprise as the telehealth wave sweeps across the United States and global markets. The market valuation of the combined companies is reportedly over $2 billion.

Once combined, the new organization will have about 1,500 workers as Grand Rounds employs more than 600 staff members and Doctor On Demand has over 900 employees. Grand Rounds, founded in 2012 and Doctor On Demand, started in 2013, are both headquartered in San Francisco, California and privately held.

Grand Rounds will be the primary…


USDA provides $43 million in funding for rural medicine and education
USDA provides $43 million in funding for rural medicine and education
… New funding from the USDA for rural healthcare and education is a step in the right direction …

Funding is welcome but more is needed to reverse the issues in rural healthcare and academics

John G. Baresky

The USDA has announced it is funding 86 projects through the Distance Learning and Telemedicine (DLT) grant program. It helps rural healthcare organizations and rural educators improve their connections with and better support their patients or students. The new flow of monies is largely attributed to new demands and issues triggered by the COVID-19 pandemic.

The healthcare, education and commerce elements of rural America were already experiencing significant issues and disadvantages before the emergence of the coronavirus in the United States.

Numerous rural hospitals and other medical care provider organizations have closed at a record pace due…


Cosela (trilaciclib) is a new FDA-approved oncology therapy manufactured by G1 Therapeutics
Cosela (trilaciclib) is a new FDA-approved oncology therapy manufactured by G1 Therapeutics
… New G1 Therapy Cosela (trilaciclib) is an important new therapy for oncology …

New oncology therapy indicated for use in the treatment of small cell lung cancer

John G. Baresky

The U.S. Food and Drug Administration (FDA) has approved a new oncology therapy developed by G1 Therapeutics. Cosela (trilaciclib) earned an indication from the FDA to decrease the incidence of chemotherapy-induced myelosuppression in adult patients when administered before a platinum/etoposide-containing regimen or topotecan-containing regimen for extensive-stage small cell lung cancer (ES-SCLC).

G1 Therapeutics expects the product to be available to the marketplace in March 2021.

Cosela is the first and only FDA-approved therapy that helps proactively deliver multilineage myeloprotection to patients with extensive-stage small-cell lung cancer being treated with chemotherapy.

The product is a kinase inhibitor that…


Robert Davis New CEO At Merck
Robert Davis New CEO At Merck
… Merck names Robert Davis as new CEO …

Present Merck CEO Kenneth Frazier is retiring in June

John G. Baresky

Global pharmaceutical giant Merck (NYSE: MRK) has named Robert Davis as their next chief executive officer. Davis joined Merck as a chief financial officer in 2014.

The company’s present CEO, the legendary Kenneth Frazier, is retiring in June. Frazier has been a prolifically successful leader at Merck and is one of the few black Fortune 500 CEOs. Ken will continue to serve on Merck’s board of directors as executive chairman during the course of a transition period.


ViiV Healthcare Launches New HIV Therapy Cabenuva
ViiV Healthcare Launches New HIV Therapy Cabenuva
… ViiV Healthcare Launches New HIV Therapy Cabenuva …

GlaxoSmithKline, Pfizer and Shionogi enterprise continues to advance its HIV-focused business mission and develop breakthrough treatments

John G. Baresky

ViiV Healthcare, a company exclusively devoted to the HIV/AIDS marketplace, has announced the FDA has approved its latest new injectable therapy combination Cabenuva (cabotegravir and rilpivirine).

The FDA also approved Vocabria (cabotegravir) which is an oral tablet formulation of Cabenuva. Voacabria should be taken in combination with oral rilpivirine (Edurant) for one month prior to starting treatment with Cabenuva to ensure the medications are well-tolerated before switching to the extended-release injectable formulation.

Cabenuva is indicated as a complete regimen for the treatment of HIV-1 infection in adults who are virologically suppressed (HIV-1 RNA less than 50 copies…


Healthcare social media strategy and tactics for 2021
Healthcare social media strategy and tactics for 2021
… 2021 healthcare social media strategy and tactics …

New social media opportunities and challenges lay ahead for healthcare marketers in 2021

John G. Baresky

Social media is a key element of many healthcare marketing strategies. Many analytical models, usage reports and other sources of measurement profile the most popular trending topics and the times of peak volume when the highest level of traffic is present on specific social media platforms.

While these provide a glimpse into the wilderness of social media, they are not enough to guide a revenue-effective healthcare social media strategy. There are further strategies and methods to refine them and a 4-phase process enables healthcare marketing professionals to precisely zero in on and productively engage their target personas.


Walgreens and AmerisourceBergen: $6.5 Billion Alliance Health Deal
Walgreens and AmerisourceBergen: $6.5 Billion Alliance Health Deal
… Walgreens Boots Alliance Spins Off Alliance Health Wholesale Business Unit For $65. Billion …

Walgreens sells majority stake of its Alliance Healthcare business unit to AmerisourceBergen

John G. Baresky

Walgreens Boots Alliance (NASDAQ: WBA) is selling a majority stake of Alliance Healthcare to AmerisourceBergen for $6.275 billion in cash and two million shares of AmerisourceBergen common stock.

The deal benefits Walgreens and AmerisourceBergen in several ways. Walgreens streamlines its business model to focus its attention on retail, mail order and specialty pharmacy plus drive the expansion of its in-store primary care clinic initiative. The company gains a substantial amount of cash plus adds to its already substantial holdings of AmerisourceBergen stock.

By adding Alliance Healthcare to its organization, AmerisourceBergen fortifies its competitive position against Cardinal, Henry…


NorthShore University HealthSystem Buys Northwest Community Healthcare
NorthShore University HealthSystem Buys Northwest Community Healthcare
… NorthShore University HealthSystem Acquires Northwest Community Healthcare …

Chicago healthcare marketplace competition heats up

John G. Baresky

NorthShore University HealthSystem has formally completed its acquisition of Northwest Community Healthcare. NorthShore University HealthSystem (NSUHS or “NorthShore”) is based in the Chicago suburb of Evanston Northwest Community Healthcare (NWCH or “Northwest Community”) is located in the Chicago suburb of Arlington Heights.

NWCH was established in 1959 and has grown as the surrounding communities it supports became more densely populated. Its location and patient population made it very attractive for Chicago area health systems and others to consider buying them. Northwest Community attributes include:

  • 509-bed hospital
  • Approximately 4,000 employees
  • 1,200 doctors on staff at more than 40…

Bare Sky Marketing — Healthcare Content Writing

Authentic, fact-based healthcare content marketing writing for medical, business, academic, patient and consumer audiences https://www.BareSkyMarketing.com/

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store